메뉴 건너뛰기




Volumn 133, Issue 12, 2000, Pages 999-1001

Hormones to prevent coronary disease in women: When are observational studies adequate evidence?

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESTROGEN; GESTAGEN; PLACEBO;

EID: 0034687855     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-12-200012190-00016     Document Type: Review
Times cited : (30)

References (17)
  • 6
    • 77957126077 scopus 로고
    • Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women The Postmenopausal Estrogen/Progestin Interventions (PEPI)
    • Trial The Writing Group for the PEPI Trial. [PMID: 0007807658]
    • (1995) JAMA , vol.273 , pp. 199-208
  • 15
    • 0032985626 scopus 로고    scopus 로고
    • Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: Transdermal matrix patch versus oral estrogen therapy
    • PMID: 0010538456
    • (1999) Am J Manag Care , vol.5 , pp. 779-785
    • Ettinger, B.1    Pressman, A.2
  • 16
    • 0018962999 scopus 로고
    • Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project
    • PMID: 0006999345
    • (1980) N Engl J Med , vol.303 , pp. 1038-1041


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.